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Post-translational modifications hugely increase the
functional diversity of proteomes. Recent algorithms
based on ultratolerant database searching are forg-
ing a path to unbiased analysis of peptide modifica-
tions by shotgun mass spectrometry. However,
these approaches identify only one-half of the modi-
fied forms potentially detectable and do not map the
modified residue.Moreover, tools for the quantitative
analysis of peptide modifications are currently lack-
ing. Here, we present a suite of algorithms that allows
comprehensive identification of detectablemodifica-
tions, pinpoints the modified residues, and enables
their quantitative analysis through an integrated
statistical model. These developments were used
to characterize the impact of mitochondrial hetero-
plasmy on the proteome and on the modified pepti-
dome in several tissues from 12-week-old mice.
Our results reveal that heteroplasmy mainly affects
cardiac tissue, inducing oxidative damage to pro-
teins of the oxidative phosphorylation system, and
provide amolecular mechanism explaining the struc-
tural and functional alterations produced in heart
mitochondria.
INTRODUCTION
Shotgun mass spectrometry (MS)-based proteomics (Link et al.,
1999) has become a powerful tool for biotechnological and
biomedical research. Advances in speed and sensitivity allow
the generation of millions of spectra per experiment, but only a
minority of these spectra can be mapped to proteins (Griss
et al., 2016; Skinner and Kelleher, 2015). A large proportion of
unassigned spectra are thought to arise from peptides contain-
ing sequence variants or unknown chemical and post-transla-
tional modifications (PTMs) (Griss et al., 2016), and their charac-Cell
This is an open access article under the CC BY-Nterization is one of the most interesting and challenging goals in
proteomics. A number of computational methods have been
proposed for the detection of these unmatched peptides (Bern
et al., 2007; Chen et al., 2009; Griss et al., 2016; Kim and Pevz-
ner, 2014; Ma and Lam, 2014; Shortreed et al., 2015). Recently,
an ‘‘open search’’ (OS) strategy, where precursor mass toler-
ances of hundreds of daltons were used with a conventional
search engine, was reported to identify modified peptides at
an unprecedented scale (Skinner and Kelleher, 2015). Another
report demonstrated that OS can be performed at orders-of-
magnitude faster speeds using a fragmentation-ion indexing al-
gorithm (MSFragger) (Kong et al., 2017). These two methods
may have a considerable impact on the field, opening the way
to true hypothesis-free analysis of PTMs by MS; however, OS
algorithms still rely on the chance that the modification leaves
enough unaffected fragment ions for matching by the search en-
gine (Figure 1A). OS strategies can therefore identify only
approximately one-half of the modified peptides detectable by
conventional ‘‘closed’’ searches (CS) (Chick et al., 2015). More-
over, existing OS approaches cannot directly identify the
modification site. A further important consideration is that OS
methods have not previously been used to quantify PTM alter-
ations, and a general statistical model for the analysis of data
of this kind is currently lacking.
Here, we present a suite of bioinformatics tools designed to
overcome these limitations. Our tools double the coverage
attained by existing algorithms, enabling the generation of
comprehensive peptide maps that include practically all of the
modifications potentially detectable by MS and CS of the data-
base. Our approach also allows accurate location of the modi-
fied residues and quantitative analysis of PTMs in the context
of proteome-wide studies. We demonstrate the performance
of our tools by performing a comprehensive, tissue-specific
characterization of PTMs induced by mitochondrial hetero-
plasmy in a mouse model. Heteroplasmy has recently attracted
the attention of the biomedical community because it can be
produced during mitochondrial replacement therapies aimed at
preventing transmission of pathogenic mutations in mitochon-
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Figure 1. Overview and Peptide Identification Performance of Comet-PTM
(A) Conventional OS methods can identify modified peptides from MS/MS spectra, but only the fragments unaffected by the modification (orange square) are
matched; this effect diminishes the score assigned to modified peptides, decreasing identification performance.
(B) Comet-PTM first calculates the difference between the mass of the candidate and the mass of the precursor ion detected by the MS (Dmass). DMass is then
iteratively added to each amino acid in the peptide sequence, and the position that yields the best score is selected as the correct match.
(C) The HeLa dataset from the original OS article (Chick et al., 2015) was searched using Comet in closed search (CS) mode with three variable modifications (Met
oxidation, Asn and Gln deamidation, and Ser and Thr phosphorylation), with Comet in OS mode, or with Comet-PTM (500-Da tolerance in the latter two cases).
The scores obtained for the same spectra in the different searching conditions are compared. Yellow points in the rightmost graph are PSMs that match peptides
with more than one modification in CS mode.
(D) Identification performance of OS and Comet-PTM relative to CS in the populations of peptides modified by oxidation, deamidation, or phosphorylation. The
number of PSMs was obtained after filtering by the score threshold corresponding to 1% FDR in the CS. PSMs matching peptides with more than one modi-
fication in CS are indicated by orange bars.
(E) Frequency distribution of PSMs obtained by OS and Comet-PTM as a function of Dmass.
(F–M) Details of the frequency distribution around oxidation (F), formylation (G), aminoethylbenzenesulfonylation (H), iron (I), iodination (J), 13C (K), carbamylation
(L), and pyroglutamylation (M). The charts to the right of (L) and (M) show the distribution of PSMs as a function of the quantile position of the modification in the
peptide sequence assigned by Comet-PTM.
See also Figure S1.
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et al., 2015). Mitochondrial heteroplasmy in mice can be genet-
ically unstable and produce adverse physiological effects
(Sharpley et al., 2012). The exact molecular mechanisms that
produce the pathological effects are unclear and the potential
health risk produced by heteroplasmy in the offspring is debated.
Our results show that heteroplasmy between nonpathological
mitochondrial DNA variants induces an array of oxidative modi-
fications in the heart that predominantly affect proteins of the
oxidative phosphorylation system. The tools presented here
thus improve our ability to interpret the totality of information
present in MS/MS datasets and provide proteome-wide per-
spectives for systems biology analysis in high-throughput
proteomics.
RESULTS
Comet-PTM Enables Comprehensive Identification of
Peptide Modifications
We developed Comet-PTM, an improved OS engine that takes
into account the mass shift produced by the modification in
the fragmentation series, producing the same score as a CS
search using the same mass increment as a variable modifica-
tion (Figure 1B). To test the performance of Comet-PTM, the
results were compared with those obtained with OS and with
CS using three common variable modifications. As expected,
OS assigned higher scores to a large population of peptide-
spectrummatches (PSMs) containingmodifications not included
in the CS list of variable modifications (Figure 1C, left). However,
CS assigned a higher score than OS to a large population
of PSMs with modifications included in the CS list, because
the modifications affected the matching of fragment ions,
decreasing the OS-assigned score (Figure 1C, left). This effect
reduced the identification performance of OS to around 50%
of the PTMs identified by CS (Figure 1D), confirming previous re-
sults (Chick et al., 2015). In contrast, scores obtained with
Comet-PTM matched or exceeded OS (Figure 1C, center). In
addition, Comet-PTM identified the same Dmass peaks as OS
(Figure 1E); however, most of these peaks contained about
2-fold more PSMs (Figures 1E–1J), reflecting the superior perfor-
mance. As expected, this effect was not observed when the
modification did not affect the fragmentation series. Thus, the
13C peak, produced by errors in assignment of the monoisotopic
precursor mass, was observed with exactly the same number of
PSMs (Figure 1K). The number of PSMswas also similar formod-
ifications in N-terminal position of the peptide, which only affect
b-series and have a negligible effect on identification by higher-
energy collisional dissociation (HCD) fragmentation (Figures 1L
and 1M).
Comet-PTM produced scores similar to or higher than those
obtained with CS (Figure 1C, right), except for a small population
of peptides for which CS found two or more modifications (Fig-
ure 1C, orange dots). This effect was not due to differences be-
tween CS and Comet-PTM scores (Figures S1A and S1B).
Therefore, and unlike OS, Comet-PTM had a similar identifica-
tion performance to that of CS for the preselected modifications
(Figure 1D). In several instances, Comet-PTM correctly located
an oxidation on Trp, Pro, or Tyr that CS wrongly assigned to
oxidation on Met, the predefined variable modification residuein CS (Figures S1C–S1E). This finding shows that conventional
PTM searches using a variable modification on selected amino
acids can force false assignation of the modified residue. Taken
together, these data show that the Comet-PTM OS engine effi-
ciently resolves the modification mass shift in the fragmentation
series, doubling the number of modified peptides identified by
conventional OS and matching the identification performance
of targeted CS.
Comet-PTMDetects the Location ofModifications in the
Peptide Sequence
Peptides were identified after Comet-PTM searches with
SHIFTS, an algorithm that detects the peaks in the Dmass distri-
bution and controls the peptide false-discovery rate (FDR)
through a conservative, three-layered approach (Figures 2A–
2C; see also STAR Methods). From the output of a search
against a concatenated target-decoy database, SHIFTS calcu-
lates a global score threshold to control FDR in the population
of PSMs with Dmass greater than 56 Da (Figure 2A). A local
score threshold is also defined to control FDR separately within
each of the 1-Da bins in the Dmass distribution (Figure 2B).
Finally, a peak score threshold is calculated to control FDR sepa-
rately within each peak detected in the Dmass distribution (Fig-
ure 2C). A PSM is considered to be correctly identified when
its score is above the global and peak thresholds; when a PSM
does not form part of a peak, instead of the peak threshold the
local threshold is used. This conservative approach allows full
control of FDR, avoiding any bias due to the specific behavior
of certain kinds of peptide modifications that may bemore prone
to match decoy sequences.
An advantage of Comet-PTM over existing OS approaches is
that it automatically assigns themodification to the residue in the
peptide sequence that produces the best score and therefore is
the modified position that best explains the fragmentation data.
Assigning modifications to specific residues is considered a
much less reliable process than identifying peptides, partly
because there is frequently insufficient information to determine
the exactmodified residue (Chalkley et al., 2008). To estimate the
accuracy of Comet-PTM assignation of amodification to the cor-
rect site, we filtered correct identifications using the conservative
method described above with a 1% FDR threshold and then
calculated the fraction of PSMs in which the mass shift was
located in amino acids predicted to harbor well-knownmodifica-
tions. Oxidation was located to Met, Trp, or Pro in 82% of cases,
and deamidation to Asn, Gln, or carbamidomethylated Cys in
86% of cases (Figure 2D). Considering six well-known modifica-
tions, the overall accuracy of Comet-PTM was estimated at
85%. To test more specifically the performance of Comet-
PTM for the correct assignation of phosphorylation sites, we
analyzed a dataset obtained from synthetic phosphorylated
peptides (Ferries et al., 2017). Comet-PTM assigned the correct
position with 81% accuracy, and in 94% of the cases the modi-
fication was in the correct or in an adjacent position (Table S1).
We then analyzed which amino acids were assigned to known
modifications with a higher frequency than expected by chance.
Among the most frequent, we only found well-known modifica-
tions like oxidized Met and Trp, deamidated Asn, Gln and carba-














































































































































































































Figure 2. Identification of Modified Peptides and Location of the Modified Site
(A) DMass distribution of target and decoy PSMs and range of application of the global score threshold. The vertical scale is enlarged to show the distribution of
decoy PSMs.
(B) Local score thresholds applied in each 1-Da bin in the Dmass distribution.
(C) Peak score thresholds applied to the peaks detected by SHIFTS in the Dmass distribution.
(D) Percentage of successful assignment of the indicated modification to the indicated residues.
(E) Inset horizontal bar graphs plot the frequency distributions of PSMs assigned by Comet-PTM to the indicated amino acids and modifications. Vertical bar
graphs: frequency of PSMs assigned to the indicated amino acids after subtracting the average frequency of the three previous and the three subsequent
positions. Residues that accumulate counts in the histogram at position 0 are labeled in red.
See also Figures S2 and S3.Trp, and kynurenine-modified Trp (Figure 2E). Some Pro modifi-
cations were also found with the Dmass of kynurenine-modified
Trp (Figure 2E), but all of them corresponded to homologous
peptides that contained the Pro>Thr substitution, which has
the same Dmass (Figure S2), and that were assigned the same
score. Finally, Trp iodination was also clearly detected above
background (Figure 2E). This modification was unexpected
because, although Trp halogenases have been described in bac-
teria (van Pée and Patallo, 2006), they are not present in mam-
mals, and Trp iodination has not been described before as a
chemical artifact. The majority of peptides containing iodinated
Trp contained neither Tyr nor His, the two amino acids known
to react with iodine. A careful inspection of their fragment
spectra confirmed the presence of y-fragments that could only
be explained by Trp being the modified residue (Figure S3). In
addition, the only modification described in Unimod that
matched the observed mass shift corresponded to iodination.
From all of these data, we concluded that Trp was iodinated in
these peptides, most probably as a side-chain reaction of the
iodine produced from the Cys-alkylating reagent iodoacetamide.
This finding further highlights the accuracy with which Comet-3688 Cell Reports 23, 3685–3697, June 19, 2018PTM locates the site of modification and suggests that this OS
engine may be useful for detecting novel peptide modifications
in specific amino acids.
A Single Integrated Statistical Framework Allows
Quantification of the Proteome and of the Modified
Peptidome
For the quantitative analysis of modified peptides, we developed
an algorithm based on a previously proposed systematic work-
flow (Garcı́a-Marqués et al., 2016; Navarro et al., 2014) (Fig-
ure 3A). The algorithm includes a peptide-to-protein integration
step that quantifies protein values from the unmodified peptide
forms and then computes the standardized log2-ratio of the
modified peptides with respect to these protein values ðZpqÞ(Fig-
ure 3B). This makes it possible to detect modified peptides
whose behaviors deviate significantly from those of the unmod-
ified peptides from the same protein. Note that the algorithm cal-
culates peptide abundances relative to the parent protein, not to
themean of all the peptides in the sample, so that changes at the
peptide level are unaffected by changes in protein abundance.
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Figure 3. Quantitative Analysis of Alterations Produced by Heteroplasmy in the Modified Peptidome and in the Proteome
(A) Scheme of the integrative workflow used to quantify modified peptides, proteins or categories. Each arrow represents a step performed with the generic
integration algorithm (Garcı́a-Marqués et al., 2016). Standardized log2-ratio values at the peptide level ðZpqÞ are obtained from the peptide-to-protein integration.
The algorithm provides corrected peptide values by taking account of the corresponding protein changes. The same workflow is used for protein quantification
and systems biology analysis of coordinated protein responses with the SBT model (Garcı́a-Marqués et al., 2016).
(B) Scheme of the generic integration algorithm (GIA) (Garcı́a-Marqués et al., 2016) adapted for the analysis of modified peptides in the peptide-to-protein
integration step. The relations table include tags that can be used to indicate that modified peptides are excluded from the computation of protein averages.
(C) Distributions of Zpq values for nonmodified (Non-Mod) and modified peptides (Mod). These data come from the analysis of mouse tissues in a model of
mitochondrial heteroplasmy; each graph corresponds to a tissue from an individual animal. The inset plots show the Zpq distributions for peptides containing the
kynurenin Trp modification. Note that the distribution is displaced to the right in the hearts of heteroplasmic mice, indicating increased abundance. For further
details, see STAR Methods.
(D) Characterization of coordinated protein alterations produced by heteroplasmy in heart, liver, and muscle using the SBT model. Zqa values are standardized
log2-ratio averages of proteins from heteroplasmic mice relative to controls. Proteins are grouped into representative functional categories with a statistically
significant change. The upper panel presents proteins in the OXPHOS category that are decreased in the heteroplasmic heart and that contain heteroplasmy-
induced oxidative modifications (Figure 6).
See also Table S2.unmodified and modified peptide forms precisely followed the
expected null hypothesis distribution in different tissues from
two mouse strains (Figure 3C). These results convincingly
demonstrate that the quantitative behavior of the entire popula-
tion ofmodified peptides can bemodeled accurately, providing a
robust statistical framework within which to analyze abundance
changes in high-throughput experiments. This allowed detectionof significant changes in certain modified peptides against the
null hypothesis in specific situations (Figure 3C, lower left).
The same workflow used for peptide quantitation allowed the
analysis of protein abundance changes and the characterization
of functional categories that were affected by the coordinated
action of proteins, using the systems biology triangle (SBT)
model (Garcı́a-Marqués et al., 2016) (Figure 3A). This statisticalCell Reports 23, 3685–3697, June 19, 2018 3689
design thus allowed a full description of the alterations in the
modified peptidome in the global context of changes in the
proteome.
Heteroplasmy Produces Protein Alterations Consistent
with a Mitochondrial Dysfunction in the Heart
We used Comet-PTM and associated tools to study the molec-
ular impact of mitochondrial heteroplasmy on the proteome
and the modified peptidome in heart, liver, and skeletal muscle
from 12-week-old mice. This age was considered the most
appropriate to study molecular alterations before more exten-
sive damage was produced as a consequence of hetero-
plasmy. SBT model analysis of the quantitative protein data
from the heart revealed a coordinated decrease of proteins
related to muscle function and the oxidative phosphorylation
system (OXPHOS) and a coordinated increase of tubulins,
myosins, and proteins involved in vesicle trafficking. The mus-
cle-function proteins included KCRS (mitochondrial creatine ki-
nase) and VDAC3, which are key suppliers of phosphocreatine
to the sarcomere, and SGCG and KGP1, which are essential for
sarcomere contraction (Table S2). These alterations in hetero-
plasmicmice are highly consistent with the decreased ATP syn-
thesis and the abnormal increase in phosphocreatine/ATP ratio
in the heart and with the increase in plasma creatine kinase we
have observed in this animal model (unpublished data), and
provide evidence that heteroplasmic cardiac mitochondria
have a compromised ability to supply energy to the sarcomere.
Among the increased vesicle trafficking proteins, STXB3 and
VAMP2 are implicated in the insulin-dependent movement of
GLUT4 from inner vesicles to the plasma membrane. This
finding also agrees with a higher glucose uptake we detected
in heteroplasmic hearts, pointing to a shift toward glycolytic
metabolism in order to compensate the reduced phosphocrea-
tine supply from the OXPHOS. The coordinated decrease in
blood proteins and the increase in heart cytoskeletal proteins
in heteroplasmic animals suggest a homeostatic effort to main-
tain cardiac cell structure.
Heteroplasmy did not affect OXPHOS protein levels in liver but
did produce a coordinated increase of docosahexaenoic acid
(DHA) signaling pathway proteins (Figure 3D), including AKT2,
BID, and B2CL1 (Table S2). AKT2 plays an essential role in the
progression of the inflammatory response and apoptosis (Ló-
pez-Carballo et al., 2002); consistent with this finding, we de-
tected signs of inflammation in the liver of heteroplasmic mice
with aging (unpublished data). Heteroplasmic liver also showed
coordinated increases in a group of myosins and phosphatidyli-
nositol pathway proteins, probably reflecting a homeostatic
response. These data thus indicate that, at 12 weeks of age, het-
eroplasmy produces a decrease in OXPHOS proteins in the
heart, probably reflecting mitochondrial dysfunction, but the
same effect is not seen in liver.
In heteroplasmicmuscle, we detected a coordinated decrease
of proteins regulating cell shape, such as tubulins and microtu-
bule proteins (Figure 3D). On the other hand, the thick-filament
myosins, as well as calcium transporting proteins, were
increased, suggesting the induction of compensatory mecha-
nisms. However, we found no evidence of altered mitochondrial
protein levels in muscle at this age.3690 Cell Reports 23, 3685–3697, June 19, 2018Heteroplasmy Mainly Produces Oxidative Modifications
of OXPHOS Proteins in Heart
To study the impact of heteroplasmy on themodified peptidome,
we first compared the Dmass distribution of peptides searched
with Comet-PTM and identified with SHIFTS in the three tissues.
The distribution of the most abundant peaks was very similar in
liver, heart, and muscle (Figure S4). In addition to the most
intense peak corresponding to unmodified peptides, we found
peaks corresponding to oxidized and deamidated peptides,
and dioxidized peptides were also frequent. Other frequentmod-
ifications were artifacts produced by TMT reagents and iodoace-
tamide treatments, sodium adducts, and missed cleavages.
Some tissue-specific modifications were also detected, mostly
in the region from 50 to 100 Da. Among these, phosphorylated
peptides were more abundant in muscle and 90% of these pep-
tides belonged to proteins implicated in muscle contractility,
consistent with the regulatory role of phosphorylation in the
sarcomere. Within each Dmass peak, we analyzed the distribu-
tion of the modified amino acid residues, which were assigned
to frequent modifications using the unbiased approach followed
in Figure 2E. Confirming the results described above, amino
acids known to harbor specific modifications were mostly
located correctly (Figure S5). Interestingly, the relative propor-
tion of modified sites was remarkably preserved across the three
tissues, with the exception of tyrosine iodination, which was
prominent in heart but less frequent in liver and skeletal muscle
(Figure S5). This analysis also detected the increased frequency
of phosphorylation in muscle (Figure S5). We estimated that
about one-quarter of the total peptidome in the three tissues
had known PTMs, mostly oxidation and deamidation; less than
10% of modifications were chemical artifacts (Figure 4A).
Second, we analyzed the quantitative data with the integrative
statistical algorithm (Figure 3A) to determine the pattern of mod-
ifications that are specifically affected by heteroplasmy in each
tissue. Heteroplasmy induced marked tissue-specific modifica-
tions, most of them concentrated in heart and barely detectable
in skeletal muscle (Figure 4B; Table S3). The vast majority of
increased modifications in heart were oxidative, affecting mostly
Tyr, Trp, Pro, and Phe and to a lesser extent Asn, Cys, and Asp
(Figure 4C). Heteroplasmy also induced phosphorylation and
methylation in the heart. The modification pattern was similar
in liver, but the effect of heteroplasmy in this tissue was signifi-
cantly less pronounced.
Functional enrichment analysis revealed that heteroplasmy-
induced modifications in mouse heart were mostly located in
mitochondrial proteins, particularly those located in the inner
mitochondrial membrane; moreover, most of the modified pro-
teins were OXPHOS proteins, which were enriched with multiple
oxidative modifications (Figure 5A). Tricarboxylic acid (TCA) cy-
cle proteins and those related to the oxidoreductase complex
were enriched in several modifications. Deamidation affected
several mitochondria-related categories, and phosphorylation
affected proteins related to contractility. Heteroplasmy-induced
modifications affected considerably fewer categories in liver
(Figure 5B) and were not significantly enriched in muscle (Fig-
ure 5C), where only a few categories were decreased, containing
low numbers of proteins. Deamidated peptides were found in
proteins related to mitochondria, NAD binding, and extracellular
Figure 4. Alterations Produced by Heteroplasmy in the Modified Peptidome in Different Mouse Tissues
(A) Complete map of the basal peptidome, expressed as a percentage of the total number of peptides identified in each tissue (circular bar graphs: h, heart; l,
liver; m, muscle). For simplicity, peptides oxidized onMet (light blue) are included in the group of nonmodified peptides. The plot to the right shows proportions of
artifacts produced by sample manipulation.
(B) Number of PTM-containing peptides significantly increased (+) or decreased () in heteroplasmic mouse tissues (n = 4) relative to controls (n = 3).
(C) Statistically significant PTM increases in heteroplasmic mouse tissues according to the type of modification and the modified residue. The circular inner bars
show the peptide proportion for eachmodification in the basal state, and the radial red bars represent the proportion of peptides of each kind (in parts per 10,000)
that are increased in heteroplasmic tissues. For the sake of clarity, three different scales are used depending on the type of modification. DeA, deamidation; meth,
methylation; phos, phosphorylation; MC, missed cleavages; Chem, chemical derivatives produced by sample preparation; TMT, extra addition of the isobaric
labeling reagent; Adducts, Na, K, and ammonia adducts. Uppercase letters indicate the single-letter amino acid code. ox, oxidation; 2ox, dioxidation; 3ox,
trioxidation; Kyn, Trp to kynurenine; OH, Trp to hydroxytryptophan; NFK, Trp to N-formyl kynurenine; 2HFK, Trp to 2-hydroxy formyl kynurenine; red triangle, Trp
to oxolactone; red square, Trp to quinone; q, quinone, Tyr to quinone; Iodo, iodination; asterisk, Met to homocysteic acid; hashtag, Met to homoserine.
See also Figures S4 and S5 and Table S3.exosomes in both heart and liver, suggesting that these modifi-
cations do not contribute to tissue-specific phenotypic differ-
ences between heteroplasmic and control mice.
Interestingly, heteroplasmy decreased phosphorylations in
proteins related to chaperone activity in the heart but had the
opposite effect in liver (Figures 5A and 5B). This category con-
tains the two HSP90 isoforms (HSP90AA1 and HSP90AB1),
which harbor PTM sites involved in the regulation of the chap-
erone activity (Mollapour and Neckers, 2012). These isoforms
are known to be phosphorylated at Ser263 and Ser255, respec-
tively (Hu et al., 2015; Wang et al., 2017), within the CK2 phos-
phorylation motif (S-X-X-E), which is crucial for protein activity.
In particular, phosphorylation at Ser255 is required for the activa-tion of mitogen-activated protein kinase (MAPK)/extracellular
signal-regulated kinase (ERK) pathway. Comet-PTM and
SHIFTS identified these two phosphorylated sites, and hetero-
plasmy decreased their levels in heart while increasing them in
liver (Figure 5D). These findings suggest that heteroplasmy
differentially affects chaperone activity and support the roles in
cardiac heteroplasmywe have proposed for the endoplasmic re-
ticulum and the mitochondrial unfolded stress response (unpub-
lished data).
Heteroplasmy also altered phosphorylation levels at sites
known to regulate protein activity in a tissue-specific manner.
Phosphorylation at Ser42 from PTRF, which regulated transcrip-
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2010; Liu and Pilch, 2016), was decreased in heart but was
increased in muscle, in agreement with the different metabolic
status of these tissues (Table S3). Similarly Ser133 from MYG,
which regulates contractility (Lundby et al., 2013), was more
phosphorylated in heart, in line with the coordinated decrease
of proteins related to muscle function (Figure 3D), suggesting al-
terations in the contractile function of the heart in heteroplasmic
animals. In the liver, the active site Ser117 from PGM1, which
regulates glycogen biosynthesis (Huttlin et al., 2010; Lee et al.,
2014), was less phosphorylated, suggesting lower fuel storage
in this tissue (Table S3). These results reinforce the notion that
the impact of heteroplasmy is tissue specific. The rest of phos-
phorylated sites affected by heteroplasmy had unknown regula-
tory roles, but it should be noted that all of them have been
described previously, supporting the accuracy of the algorithms
used to detect them. They include Ser181 in PGRMC1 (Jin et al.,
2004), Ser442 in SRCA (Dai et al., 2007), Ser475 in JPH1 (Rigbolt
et al., 2011), and Ser298 and Ser304 in BIN1 (Ballif et al., 2004;
Huttlin et al., 2010) (Table S3).
To compare the alterations in the modified peptidome with the
changes observed at the protein level, we mapped the proteins
harboring PTMs affected by heteroplasmy onto the protein dis-
tribution plots depicting coordinated protein responses (red
and blue dots in Figure 3D). Most increased modifications map-
ped onto the OXPHOS protein category in heart, which was
decreased, whereas proteins belonging to other categories
were mostly unaffected. This finding suggests that the oxidative
damage produced by heteroplasmy in heart OXPHOS proteins
induced their degradation, and is consistent with the increase
in oxidative stress we have observed in heart slices, embryonic
fibroblasts, and adult fibroblasts of heteroplasmic mice (unpub-
lished data).
Most heteroplasmy-induced oxidative modifications in
OXPHOS proteins occurred in the four respiratory protein com-
plexes, except for Trp oxidations, which were mostly concen-
trated in C-IV (Figure 6). The modifications were clustered in
groups of proteins located together in the structure of the com-
plexes and predominantly affected proteins oriented toward the
mitochondrial matrix, where proteins are more exposed to mito-
chondrial reactive oxygen species (ROS). In further analysis, we
used Consurf to calculate evolutionary conservation profiles for
the affected residues (Ashkenazy et al., 2016) and mapped the
modifications onto the known three-dimensional (3D) structures
of the complexes, when available, or onto their predictedmodels
(Meier and Söding, 2015). We found that 70% of the modified
residues were conserved or interacted with conserved regions
(Table S4). Moreover, most of the modifications were located
on the protein surface, and those that were buried tended to
have high conservation scores, suggesting they are important
for structural stability or folding (Table S4). These findings sug-Figure 5. Functional Distribution of Proteins Post-translationally Modi
(A–C) Functional enrichment analysis of the proteins containing PTMs that are sign
or muscle (C) of heteroplasmic mice in relation to control mice. The analysis was p
represents the number of proteins in each category. Asterisks indicate statistica
each tissue. Inner circular rings are used for categories at the cellular componen
(D) Heatmap of the Zpq values for two modified proteotypic peptides from the two
replicates in the heart and in liver. These two isoforms are included in the ‘‘chapgest that these oxidative modifications compromise OXPHOS
protein function. This view is supported by the decreased ATP
synthesis capacity we have detected in heteroplasmic heart.
DISCUSSION
Comprehensive analysis of PTMs inmass spectrometry data ob-
tained through shotgun approaches has historically presented a
bioinformatics challenge because conventional (or closed) data-
base searches can only identify predefined subsets of modifica-
tions. This limitation impedes truly hypothesis-free analysis of
modifications, to the point that the proportion of chemical and
PTM in biological systems has remained unknown. The open
database search strategy (Chick et al., 2015) provided a starting
point for resolving this problem, allowing a truly unbiased high-
throughput identification of modified peptides without previous
knowledge on the nature of these modifications. An improved
fragment-ion indexing method (MSFragger) later demonstrated
that OS can be performed on a timescale similar to or shorter
than that required for CS (Kong et al., 2017). The open-search
strategy has the additional advantage that modified and nonmo-
dified peptide forms are identified simultaneously (Kong et al.,
2017). These strategies, however, are not comprehensive and
provide limited information on the nature of modified residues.
The computational approach presented here enables the
open-search strategy to match the performance of CS, identi-
fying the vast majority of detectable peptide modifications.
Although Comet-PTM is built on the framework of a well-known
database searching engine, it is important to note that the under-
lying concept can be extrapolated to any other searching engine,
opening the way to near-complete analysis of the protein-modi-
fication landscape in biological systems using tools already used
by the proteomics community. In addition, our method provides
information on the most probable site containing the modifica-
tion with an estimated accuracy of 85%. It should be noted
that, in its current state of development, the method might fail
if the peptide contains more than one modification. However,
the impact of this limitation on the general performance of the al-
gorithm seems small, since the fraction of multiply modified pep-
tides that were not identified was almost negligible. We also
introduced a conservative, three-layered approach to control
the FDR of peptide identification. Our local FDR calculation is
similar to that used by MSFragger (Kong et al., 2017), with the
only difference that we used the decoy/target competition strat-
egy to estimate FDR, whereas Kong et al. modeled local score
distributions, in the same 1-Da bins, as a mixture of correct
and incorrect identifications and calculated the probability of
correct identification by the Bayes rule. As recognized by these
authors, their approach did not take into account the parts-
per-million levels of accuracy produced by high-resolutionfied by Heteroplasmy
ificantly increased (brown scale) or decreased (blue scale) in heart (A), liver (B),
erformed separately per different kinds of modification (slices). Color intensity
l significance of category enrichment relative to the list of proteins identified in
t level, whereas outer rings correspond to biological processes.
HSP90 isoforms (HSP90AB1 and HSP90AA1) for all control and heteroplasmic
erone protein assembly’’ functional category displayed in (A) and (B).







































































































































































































































































Figure 6. PTMs Induced by Heteroplasmy in OXPHOS Proteins
(A–D) Scheme of heteroplasmy-induced PTMs in proteins of complex I (A), complex IV (B), complex III (C), and complex V (D) from the OXPHOS system. PTM-
containing proteins are highlighted in red, with the spatial position of the modified residue indicated. The heatmaps show statistically significant changes in
(legend continued on next page)
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instruments (Kong et al., 2017), which we have considered in our
model by applying an additional peak FDR estimation. In addi-
tion, we found it necessary to introduce a third global FDR filter
to avoid identification of low-scoring peptides in local bins or
in peaks that, as in the case of oxidation, concentrate high
numbers of target PSMs.
The algorithm allowed us to produce peptide maps containing
realistic proportions of unmodified peptides, PTMs, and chemi-
cal artifacts in mouse tissues, and of amino acid residues
subjected to each type of modification. We show that the basal
distribution of modifications and modified amino acids is
remarkably similar across the three mouse tissues studied, indi-
cating that the algorithm generates reproducible results and that
most peptide modifications are of an oxidative nature. Many of
the modifications are introduced during sample preparation,
including those induced by exposure to Cys-alkylating and
amine-directed isobaric labeling reagents; although these
agents are thought to be highly specific, in practice they produce
secondary reactions with other nucleophiles.
The ability to perform a truly hypothesis-free high-throughput
analysis of modifications can contribute to a deeper understand-
ing of the relation between protein chemistry and function;
however, the most important biological insight obtainable with
shotgun proteomics is how these modifications are altered dur-
ing normal physiological processes or as a consequence of dis-
ease. Detecting these specific alterations allows to concentrate
the study on biologically meaningful modifications, obviating the
analysis of the abundant artifacts produced by sample prepara-
tion. The statistical approach presented here enables quantita-
tive analysis of the modified peptidome within the same frame-
work used to analyze the unmodified proteome; this approach
thus allows coherent interpretation of all of the results and opens
theway to integrated systems-biology analysis.We demonstrate
the performance of our algorithm by simultaneously character-
izing, in three tissues of a mouse model, the quantitative impact
of heteroplasmy on the proteome and on the modified pepti-
dome. To our knowledge, this is the first study to apply open-
search-based approaches together with quantitative MS, allow-
ing comprehensive and unbiased characterization of alterations
in the protein modification landscape produced in a biological
system.
Our results reveal that the major hallmark of mitochondrial
heteroplasmy in 12-week-old animals is oxidative damage to
OXPHOS proteins in the heart. This is mainly reflected in
the increased levels of oxidative modifications and in the
decreased levels of OXPHOS proteins. Our data support the
notion that heteroplasmy involving different nonpathological
mtDNA variants affects the performance of the OXPHOS sys-
tem in the heart, resulting in compromised mitochondrial ROS
handling that triggers an oxidative stress response and impairs
the ability to supply energy to the sarcomere. Heteroplasmy isabundance ðZpqÞ of the indicated peptides in heart and liver from control mice (Ctr
was not detected in the tissue sample. Modified residues that are unambiguously
blue letters. Asterisks mark statistically significant changes between control and h
type is indicated in the column to the right of the peptide sequences: ox, oxidat
droxytryptophan; NFK, Trp to N-formyl kynurenine; 2HFK, Trp to 2-hydroxy for
conservation scores of these peptides are listed in Table S4, from which the resknown to be related to ROS production (Hämäläinen et al.,
2013, 2015) and also affects the levels of contractile proteins
in muscle. These alterations do not occur in liver, which is
able to resolve heteroplasmy (unpublished data). Our data
thus provide a molecular mechanism that explains the func-
tional findings we have observed in the heteroplasmic heart,
which include a diminished ability of mitochondria to produce
ATP, increased glucose uptake, an exacerbated phosphocrea-
tine/ATP ratio, and mitochondrial disruption and structural
alterations.STAR+METHODS
Detailed methods are provided in the online version of this paper
and include the following:
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Filter Aided Sample Preparation (FASP) kit Expedeon Cat# SKU: 44250
10 plex-TMT Thermo Fisher Scientific Cat# 90110
OASIS HLB extraction cartridges Waters Corp. Cat# 186000383
high pH reversed-phase peptide fractionation kit Thermo Fisher Scientific Cat# PI84868
EASY-nLC 1200 instrument Thermo Fisher Scientific Cat# LC120
EASY-Spray NG Ion Source Thermo Fisher Scientific Cat# ES082
Q Exactive HF mass spectrometer Thermo Fisher Scientific Cat# IQLAAEGAAPFALGMBFZ
Acclaim PepMap100 C18 100 A nanoViper
Trap column.
Thermo Fisher Scientific Cat# 11352013
EASY-Spray column, 50 cm 3 75 mm ID, PepMap
RSLC C18, 2 mm particles,100 A pore size
Thermo Fisher Scientific Cat# ES803
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and BL/6 C57 -NZB males.
José Antonio Enrı́quez Lab, Centro
Nacional de Investigaciones
Cardiovasculares (CNIC)
BL/6C57, BL/6NZB and BL/6 C57 -NZB
Software and algorithms
Comet release 2016.01 Eng et al., 2013, 2015 http://comet-ms.sourceforge.net
Comet-PTM This paper https://github.com/CNIC-Proteomics/
Comet-PTM
SHIFTS (Systematic Hypothesis-free Identification of




Vseq program Cogliati et al., 2016 available upon request
Generic Integration Algorithm (GIA) This paper and Garcı́a-Marqués
et al., 2016
https://github.com/CNIC-Proteomics/
PTM-Quant-StatsCONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests should be directed to and will be fulfilled by the Lead Contact, Jesús Vázquez (jvaquez@cnic.es).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mouse Model of Heteroplasmy
All animal procedures conformed to EU Directive 86/609/EEC and Recommendation 2007/526/EC regarding the protection of ani-
mals used for experimental and other scientific purposes, enforced in Spanish law under Real Decreto 1201/2005. Themice were fed
a standard chow diet (5K67 LabDiet).
Generation of Heteroplasmic Mice
Heteroplasmic mice were generated by electro-fusing cytoplasts from conplastic BL/6NZB zygotes to recipient C57BL/6JOlaHsd
(BL/6C57) one cell embryos, cultured overnight and transplanted as two-cell embryos into pseudo pregnant Hsd:ICR (CD-1) females
to complete development to term as previously described (Jenuth et al., 1996). To the best of our knowledge, no consensus rule to
name heteroplasmic mouse strains exists. Here, we propose the following designation to name heteroplasmic mouse strains:
NUCLEAR GENOME-mtCYTOPLASMIC GENOME #1 + CYTOPLASMIC GENOME #2 [i.e., C57BL/6J-mtC57BL/6+NZB, a straine1 Cell Reports 23, 3685–3697.e1–e4, June 19, 2018
with the nuclear genome of C57BL/6J and the cytoplasmic (mitochondrial) genome of C57BL/6J and NZB]. To simplify we are calling
it BL/6C57-NZB along this report. The female heteroplasmic offspring (named BL/6C57-NZB) werematedwith C57BL/6JOlaHsdmales to
prevent nuclear genetic drift in our particular mice lines. Only offspring of the established heteroplasmic mice were used.
Mice Breeding
Heteroplasmic females (BL/6C57-NZB) were outcrossed with males BL/6C57. Only females with an initial level of NZB heteroplasmy
above 20% were used for colony maintenance.
Themice used in this workwere 12-week-old control (C57BL/6JOlaHsd strain) and heteroplasmicmales (containingmore than one
mtDNA in the same cytoplasm, C57BL/6 background). The effect of heteroplasmy on the PTMs of the proteome of different tissues
was studied on liver, heart, and skeletal muscle (gastrocnemius) samples. In the last two tissues, the heteroplasmy was stable, while
the liver was selected as a control tissue since it spontaneously selected one of the alternative variants of mtDNA (manuscript in sub-
mission For each tissue, biological replicates from different control (N = 3) and heteroplasmic mice (N = 4) were analyzed.
METHOD DETAILS
Benchmarking MS Dataset
To test the performance of the developed algorithms, we used the publicly available HEK293 dataset (Chick et al., 2015), containing
1.121.149MS/MS spectra in 24 raw files acquired on a Q-Exactive Orbitrap mass spectrometer. For the bench-marking of site local-
ization through CometPTM we used a synthetic phosphopeptide dataset from the Pride database (dataset identifier
PXD007058)(Ferries et al., 2017).
Preparation of Protein Extracts
Mice were sacrificed by cervical dislocation and liver, heart, and skeletal muscle tissues were extracted. 20 mg of each tissue were
homogenized in lysis buffer (10mM Tris-HCL pH7.4, 1 mM EDTA, 0.32 M sucrose, 2% SDS) freshly supplemented with protease and
phosphatase inhibitors (Roche) and 50 mM DTT, using a MagNA Lyser instrument (Roche). The lysate was boiled for 5 min and cell
debris were removed by centrifugation.
Protein Digestion, Peptide Labeling, and Fractionation
Proteins were treated with 50 mM iodoacetamide (IAM) and digested with trypsin using the Filter Aided Sample Preparation (FASP)
digestion kit (Expedeon) (Wisniewski et al., 2011) according to manufacturer’s instructions. Dried peptides were labeled using 10
plex-TMT reagents according tomanufacturer’s instructions (Thermo Fisher Scientific), desalted onOASIS HLB extraction cartridges
(Waters Corp.) (Leyfer and Weng, 2005), separated into 7 fractions using the high pH reversed-phase peptide fractionation kit
(Thermo Fisher Scientific) and dried-down before MS analysis.
LC-MS Analysis
Each fraction of the labeled peptide samples were analyzed using an Easy nano-flow HPLC system (Thermo Fisher Scientific)
coupled via a nanoelectrospray ion source (Thermo Fisher Scientific, Bremen, Germany) to a Q Exactive HF mass spectrometer
(Thermo Fisher Scientific, Bremen, Germany). C18-based reverse phase separation was used with a 2-cm trap column and
a 50-cm analytical column (EASY column, Thermo). Peptides were loaded in buffer A (0.1% formic acid (v/v)) and eluted with a
240 min linear gradient of buffer B (80% acetonitrile, 0.1% formic acid (v/v)) at 200 nL/min. Mass spectra were acquired in a
data-dependent manner, with an automatic switch between MS and MS/MS using a top 15 method. MS spectra were acquired in
the Orbitrap analyzer with a mass range of 400–1500 m/z and 60,000 resolution. HCD fragmentation was performed at 27 of normal-
ized collision energy and MS/MS spectra were analyzed at 60,000 resolution in the Orbitrap.
Database Search
Unless indicated otherwise, all searches were performed using Comet release 2016.01 (Eng et al., 2013, 2015) using trypsin digestion
with 1 missed cleavages (unless otherwise specified) and fixed Cys carbamidomethylation (57.021464 Da). For heteroplasmic mice
data, TMT labeling at N-terminal end and Lys was also considered as a fixed modification (229.162932 Da). Fragment ion tolerance
was 0.02 bin, 0 mass offset. Precursor tolerance type and isotope error were set to 1. Precursor charge range was 2-4, maximum
precursor charge 5 and maximum fragment charge 3. Only y- and b-ions were used for scoring.
Closed searches (CS) were performed at 5 ppm precursor ion tolerance, using three dynamic modifications: Met oxidation
(15.994915), Asn and Gln deamidation (0.984016) and Ser and Thr phosphorylation (79.966331). False discovery rates (FDR) of pep-
tide identifications were calculated using the refined method (Bonzon-Kulichenko et al., 2015; Navarro and Vázquez, 2009); 1% FDR
was used as the default criterion for peptide identification.
Open searches (OS) with Comet and Comet-PTM were performed in the same conditions as CS, except that precursor ion toler-
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Comet-PTM
Comet.PTMwas developed by modifying the open-source database search engine (Eng et al., 2015). For every sequence candidate
Comet-PTM calculates the difference between theoretical and experimental precursor mass (DMass), and adds up this mass itera-
tively to each one of the amino acid masses in the peptide sequence, calculating a Xcorr score in each one of the possible modified
forms of the peptide (Figure 1B). The selected candidate is the modified peptide form that produces the highest Xcorr. This design
allows Comet-PTM to reach the score that would have been obtained by performing a targeted CS with the same modification in the
same position. Note that the scores are not exactly identical, since CS uses the theoretical mass of themodification and Comet-PTM
estimates it from the difference between the precursor mass and the theoretical mass of the non-modified peptide, and experimental
errors on this estimate may affect fragment matching. This effect is, however, small when low ppm precursor mass accuracies are
used (Figures S1A and S1B). Comet-PTM has a user-selectable option of scoring also the non-modified peptide sequence (even
when DMass is different from zero), to take into account labile modifications (Kong et al., 2017).
Comet-PTMwas developed to take full advantage of themulti-thread design of Comet. Comet-PTM used less than 4 hr to perform
a 500 Da-wide OS of 16 LC-MS runs, containing an average of 44.390MS/MS spectra each, using a computer cluster with 16 nodes,
where each node is built of 2 x Intel Xeon E5-2695v2 at 2.40 GHz and contained 46 threads/124 gigabyte.
SHIFTS
SHIFTS (Systematic Hypothesis-free Identification of modifications with controlled FDR based on ultra-Tolerant database Search) is
a program that identifies peaks in the DMass distribution, assigns PSM to peaks and calculates FDR for peptide identification (Fig-
ure S6). SHIFTS uses as input the Thermo .raw files and the files obtained from Comet-PTM search.
Mass Recalibration
SHIFTS first recalibrates precursor peptide masses independently in each raw file. This was done by selecting a population of non-
modified peptides with a very high score (user selectable; recommended values are those yielding 0.1% global FDR or lower), which
are assumed to be true identifications and are used to calculate the systematic mass error (median deviation in m/z scale), which is
assumed to be constant in each raw file. From these data, SHIFTS also calculates the standard deviation of themass error ðsMÞ using
the median absolute deviation (MAD) method.
Peak Identification
Recalibrated DMass values were binned using 0.001 Da bins to construct the DMass distribution. The distribution was smoothed
using the median of a 7-point sliding window and then peak apexes were detected as downward zero-crossings in the first derivative
of the smoothed curve. Peak widths were similarly calculated as the zero-crossing points of the second derivative; in the current
version of SHIFTS they are computed only for informative purposes.
Peak Assignation
By default SHIFTS assigns a PSM to the closest DMass peak if the mass deviation of the PSM from the peak falls within 3sM, so that
approximately 99%of PSM in each peak are assigned. This value can be user adjusted. PSM not assigned to peaks were considered
as orphan PSM.
FDR Calculation
SHIFTS calculates FDR of identification using a conventional target/decoy strategy using the corrected Xcorr score (cXcorr) (Choi
and Nesvizhskii, 2008; Keller et al., 2002). A global FDR was calculated for each PSM as the ratio of the number of decoy PSMs
to the number of target PSMs having a cXcorr equal or higher. Decoy peptides matched by Comet-PTM were observed to be almost
as abundant as target peptides in the negative DMass region below the peak corresponding to neutral loss of Gly (Figure 2A), where
DMass peaks weremostly produced by neutral loss of amino acids. For this reason, the global FDRwas only calculated in theDMass
region above 56 Da (Figure 2A). All the PSM are required to have FDR lower than the global FDR, without exception.
In addition, local FDR filters are also applied. Some DMass peaks were observed to contain an unusually high number of decoy
PSM; to avoid matching false positive target PSM in these peaks, SHIFTS also calculates a peak FDR counting up the number of
decoys and target PSM assigned to each peak, and these PSM are required to pass the peak FDR filter in addition to the global
FDR filter (Figure 2C). Note that peak FDRs are often very low suggesting that the majority of PSM in these peaks are true, even
when they have a low cXcorr. This happens because the probability of finding a decoy PSM in a peak by chance alone is extremely
low. SHIFTS avoids matching these low scoring target PSM by applying the global FDR filter.
To apply a local filter to PSM which are not assigned to DMass peaks, e.g., to orphan PSM, SHIFTS models the periodic mass
distribution of decoy PSM into 1 Da-bins centered at the regions where DMass values concentrate, and calculates a local FDR
by counting up decoy and target PSM in each one of these regions (Figure 2B). The local FDR filter is applied to orphan PSM in addi-
tion to the global FDR filter. Default values for peptide identification were 1% for peak and local FDR; 5% for global FDR. Among the
peptides significantly changed by heteroplasmy and suspected to have relevant biological activity, including all the peptides in Table
S3, only those that passed analysis with Vseq program (Cogliati et al., 2016) were considered as trustable identifications.
Isotopic Correction
SHIFTS also performs a simple isotopic correction to minimize misassignations of the correct monoisotopic peak of the precursor.
When two PSMhaving the same sequence are encountered having aDMass differencewithin 1 ppmof themass difference expected
for either one or two 13C or one 34S, the DMass of the heaviest precursor is substituted by that of the lightest one.e3 Cell Reports 23, 3685–3697.e1–e4, June 19, 2018
Annotation of Modifications
A Python in-house script was used for semisupervised annotation of the nature of peptide modifications. The script searched DMass
values against Unimod database, taking into account the amino acid modified according to Comet-PTM output and also the preced-
ing and consecutive residues, comparing them with the list of amino acids that could be subjected to the modification according to
Unimod. If no amino acid was matched, the modification was considered as unassigned. Residues containing modifications that
were fixed in the database search were considered with and without the fixed modification; when not indicated, the amino acid
contains the fixed modification (e.g., C_oxidation means oxidation of carbamidomethylated Cys and K_oxidation, oxidation of
TMT-labeled Lys). DMass values that could not be matched were tentatively tested assuming one 13C misassignment of the mono-
isotopic mass of the precursor and also as combinations of twomodifications from a list of the most abundant modifications found in
the corresponding proteome. Unexplained DMass values were termed as unknown. MS/MS fragmentation spectra from the most
abundant modifications that changed their abundance in heteroplasmic mice and all the peptides in Table S3 were revised using
Vseq program (Cogliati et al., 2016).
QUANTIFICATION AND STATISTICAL ANALYSIS
Peptide Quantification and Statistical Analysis
The quantitative information from TMT reporter intensities was integrated from the spectrum level to the peptide level and then to the
protein level on the basis of the WSPP model (Martı́nez-Acedo et al., 2012; Navarro et al., 2014) using the Generic Integration Algo-
rithm (GIA) (Garcı́a-Marqués et al., 2016) . The algorithm was modified to include into the statistical model the quantitative values of
modified peptides as part of the automated workflow (Figure 3A). Briefly, for each sample i the values xqps = log2Si=C were calcu-
lated, where Si is the intensity of the TMT reporter corresponding to sample i in the MS/MS spectrum s coming from peptide p and
protein q, andC is the average intensity of all the TMT reporters from the control samples, which is used as a common reference. The
log2-ratio of each peptide ðxqpÞ was calculated as the weighted average of its spectra, the protein values ðxqÞ were the weighted
average of its peptides, and the grand mean ðxÞ was calculated as the weighted average of all the protein values (Navarro et al.,
2014) . The statistical weights of spectra, peptides, and proteins (wqps, wqp and wq, respectively) and the variances at each one




Q, respectively), were calculated as described (Navarro et al., 2014) .
The spectrum, peptide, and protein variances and the protein values were first determined including only non-modified peptides
(Figure 3B). In a second step, the modified peptides were included in the analysis, which was performed using the variances and
protein values calculated previously. For each modified peptide, the standardized variable ðzpqÞ was calculated as






where np is the number of non-modified peptides with which the corresponding protein was quantified. zpq expresses the deviation
between the peptide log2-ratio and the corresponding protein value in units of standard deviation. In absence of changes, the dis-
tributions of zpq followed very closely the normal distribution Nð0;1Þ (Figure 3C), validating the accuracy of the model.
Significant abundance changes of modified peptides were detected by Student’s t test comparing the zpq values of samples from
heteroplasmic mice (N = 4) with those of control mice (N = 3) (Table S2).
DATA AND SOFTWARE AVAILABILITY
Code Access
The software needed to execute the whole Comet-PTM pipeline can be downloaded from: https://github.com/CNIC-Proteomics/
Comet-PTM.
The software for Comet-PTM FDR control can be downloaded from: https://github.com/CNIC-Proteomics/SHIFTS.
The software for statistical analysis of quantitative data can be downloaded from https://github.com/CNIC-Proteomics/
PTM-Quant-Stats. A readme.txt file is provided with basic instructions to install and execute the package. Vseq is available upon
request.
The dataset of the raw files, protein databases, search parameters and results reported in this paper is available in the PeptideAtlas
repository at ftp://ftp.peptideatlas.org/ (username: PASS01085, password: TC4334fh).Cell Reports 23, 3685–3697.e1–e4, June 19, 2018 e4
